DACOMITINIB vs DALTEPARIN: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DACOMITINIB vs DALTEPARIN: Safety Overview
| Metric | DACOMITINIB | DALTEPARIN |
|---|---|---|
| Total FAERS Reports | 682 | 3,570 |
| Deaths Reported | 325 | 789 |
| Death Rate | 47.7% | 22.1% |
| Hospitalizations | 168 | 1,443 |
| Average Patient Age | 64.0 yrs | 67.7 yrs |
| % Female Patients | 52.0% | 39.7% |
| FDA Approval Date | Sep 27, 2018 | Apr 4, 2002 |
| Manufacturer | Pfizer Laboratories Div Pfizer Inc | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | SUBCUTANEOUS |
| Marketing Status | Prescription | Prescription |